Company: WFC-PC
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000072971-25-000090
Chunk: 61

Company: WELLS FARGO & COMPANY/MN
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 61
---
      | 1,750,000 |      |    |         — |        |        |  8,250,074 |     |             |  3,825,675 |     |                |         — |     |               |  18,300 |     |               | 13,844,049 |     |    |            |       |
| Fernando S Rivas               
 Senior EVP, Co-CEO of CIB      |     |      |      |           | 2024 |    | 1,145,192 |        |        |  5,344,120 |     |             | 16,292,505 |     |                | 4,050,675 |     |               |       — |     |               |          — |     |    | 26,832,492 |       |
| Bridget E. Engle               
 Senior EVP, Head of Technology |     |      |      |           | 2024 |    |   589,286 |        |        |          — |     |             | 19,285,246 |     |                | 2,236,500 |     |               |       — |     |               |          — |     |    | 22,111,032 |       |

1. For Mr. Rivas, consists of one-time signing bonus payments pursuant to the terms of his offer letter with the Company, to replace compensation forfeited by Mr. Rivas from his prior employer, which was subject to repayment under certain circumstances if his employment terminated during the first year of employment.

2. For Mr. Rivas and Ms. Engle, the stock awards consist of Restricted Share Rights (RSRs) granted pursuant to the terms of their offer letters with the Company to replace compensation forfeited by them from their prior employers. For information regarding equity grants made during 2024, see the Grants of Plan-Based Awards table, footnotes, and related narrative.

3. Under the applicable Financial Accounting Standards Board ( FASB ) Accounting Standards Codification ( ASC ) Topic 718 rules, the amount included in column (e) above for 2024 represents the fair value of the 2024 PSA or RSR award on its “grant date” (i.e., the date the HRC approved each award), based (i) for a PSA upon the then-probable outcome of the ROTCE performance condition (i.e., the target value of the award) and using a Monte Carlo simulation (